Reverse takeover transaction (Narrative) (Details) - USD ($)		1 Months Ended	12 Months Ended
	May 12, 2023	Sep. 29, 2023	Dec. 31, 2023
Business Acquisition [Line Items]
Aggregate gross proceeds through issuance of common shares			$ 5,109,950
Net liabilities assumed			2,071,580
Interactive [Member]
Business Acquisition [Line Items]
Aggregate gross proceeds through issuance of common shares	$ 5,109,950
Issuance of common shares in connection with financing (Shares)	1,277,426
Common shares, price per share	$ 4
Converted shares		7,249,999
Consolidated common shares		287,471
Common stock, conversion basis		25.219932-to-1
Percentage of shares held	3.56%
Net liabilities assumed	$ 50,000
SkinJect [Member]
Business Acquisition [Line Items]
Percentage of shares held	80.62%
Legal costs			$ 270,419
SkinJect [Member] | Conversion one
Business Acquisition [Line Items]
Converted shares	15,423,561
Consolidated common shares	4,626,876
Common stock, conversion basis	3.413443-to-1 basis
SkinJect [Member] | Conversion two
Business Acquisition [Line Items]
Convertible promissory notes converted	$ 1,000,000
Shares issued on conversion of notes	261,781
Common stock, conversion basis	one-to-one basis
SkinJect [Member] | Conversion three
Business Acquisition [Line Items]
Converted shares	6,434,000
Consolidated common shares	1,884,900
Common stock, conversion basis	3.413443-to-one basis
Former holders [Member]
Business Acquisition [Line Items]
Percentage of shares held	15.82%